These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29701613)

  • 1. Hydrazone linked doxorubicin-PLA prodrug nanoparticles with high drug loading.
    Gatti S; Agostini A; Palmiero UC; Colombo C; Peviani M; Biffi A; Moscatelli D
    Nanotechnology; 2018 Jul; 29(30):305602. PubMed ID: 29701613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rod-like cellulose nanocrystal/cis-aconityl-doxorubicin prodrug: A fluorescence-visible drug delivery system with enhanced cellular uptake and intracellular drug controlled release.
    Li N; Lu W; Yu J; Xiao Y; Liu S; Gan L; Huang J
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():179-189. PubMed ID: 30033244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
    Xu M; Qian J; Liu X; Liu T; Wang H
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polylactide-graft-doxorubicin nanoparticles with precisely controlled drug loading for pH-triggered drug delivery.
    Yu Y; Chen CK; Law WC; Weinheimer E; Sengupta S; Prasad PN; Cheng C
    Biomacromolecules; 2014 Feb; 15(2):524-32. PubMed ID: 24446700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facile Layer-by-Layer Self-Assembly toward Enantiomeric Poly(lactide) Stereocomplex Coated Magnetite Nanocarrier for Highly Tunable Drug Deliveries.
    Li Z; Yuan D; Jin G; Tan BH; He C
    ACS Appl Mater Interfaces; 2016 Jan; 8(3):1842-53. PubMed ID: 26717323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphiphilic polycarbonate conjugates of doxorubicin with pH-sensitive hydrazone linker for controlled release.
    Jiang T; Li YM; Lv Y; Cheng YJ; He F; Zhuo RX
    Colloids Surf B Biointerfaces; 2013 Nov; 111():542-8. PubMed ID: 23893028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
    Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
    ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEGylated Multistimuli-Responsive Dendritic Prodrug-Based Nanoscale System for Enhanced Anticancer Activity.
    Duan Z; Cai H; Zhang H; Chen K; Li N; Xu Z; Gong Q; Luo K
    ACS Appl Mater Interfaces; 2018 Oct; 10(42):35770-35783. PubMed ID: 30246536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photo- and pH-Responsive Polycarbonate Block Copolymer Prodrug Nanomicelles for Controlled Release of Doxorubicin.
    Kalva N; Uthaman S; Augustine R; Jeon SH; Huh KM; Park IK; Kim I
    Macromol Biosci; 2020 Aug; 20(8):e2000118. PubMed ID: 32567108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood circulation stable doxorubicin prodrug nanoparticles containing hydrazone and thioketal moieties for antitumor chemotherapy.
    Xu C; Xu L; Han R; Zhu Y; Zhang J
    Colloids Surf B Biointerfaces; 2021 May; 201():111632. PubMed ID: 33667865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Indicating Polymer Prodrug Nanoparticles for pH-Responsive Drug Delivery in Cancer Cells and Real-Time Monitoring of Drug Release.
    Kayal S; Kola P; Pal J; Mandal M; Dhara D
    ACS Appl Bio Mater; 2024 Sep; 7(9):5810-5822. PubMed ID: 39186444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
    Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
    Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication of doxorubicin nanoparticles by controlled antisolvent precipitation for enhanced intracellular delivery.
    Tam YT; To KK; Chow AH
    Colloids Surf B Biointerfaces; 2016 Mar; 139():249-58. PubMed ID: 26724466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-Assembling Doxorubicin Prodrug Forming Nanoparticles and Effectively Reversing Drug Resistance In Vitro and In Vivo.
    Mao X; Si J; Huang Q; Sun X; Zhang Q; Shen Y; Tang J; Liu X; Sui M
    Adv Healthc Mater; 2016 Oct; 5(19):2517-2527. PubMed ID: 27529558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin-doxorubicin conjugate prodrug as drug self-delivery system for intracellular pH-triggered slow release.
    Li J; Li X; Liu P
    Colloids Surf B Biointerfaces; 2020 Jan; 185():110608. PubMed ID: 31707225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release.
    Zhan F; Chen W; Wang Z; Lu W; Cheng R; Deng C; Meng F; Liu H; Zhong Z
    Biomacromolecules; 2011 Oct; 12(10):3612-20. PubMed ID: 21905663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
    Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
    Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of water soluble pH sensitive poly (vinyl alcohol)-doxorubicin conjugates.
    Rahoui N; Jiang B; Taloub N; Hegazy M; Huang YD
    J Biomater Sci Polym Ed; 2018 Aug; 29(12):1482-1497. PubMed ID: 29661115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Delivery Nanoparticles with Locally Tunable Toxicity Made Entirely from a Light-Activatable Prodrug of Doxorubicin.
    Schutt C; Ibsen S; Zahavy E; Aryal S; Kuo S; Esener S; Berns M; Esener S
    Pharm Res; 2017 Oct; 34(10):2025-2035. PubMed ID: 28791550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.